We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
(-2.6%)
Cap. Flow
-$4.15B
Cap. Flow
% of AUM
-9.34%
Top 10 Holdings %
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$309M |
| 2 |
ExxonMobil
XOM
|
+$302M |
| 3 |
Amazon
AMZN
|
+$291M |
| 4 |
Citigroup
C
|
+$253M |
| 5 |
Shopify
SHOP
|
+$238M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$383M |
| 2 |
Johnson & Johnson
JNJ
|
+$312M |
| 3 |
JPMorgan Chase
JPM
|
+$285M |
| 4 |
AT&T
T
|
+$191M |
| 5 |
Dollar General
DG
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.63% |
| 2 | Financials | 15.61% |
| 3 | Technology | 14.28% |
| 4 | Consumer Discretionary | 13.21% |
| 5 | Industrials | 5.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Allegiant Air
ALGT
$2.64B
| $19.5M | 0.04% |
286,312
-67,088
| -19% | -$4.89M |
|
452
PUT
Palo Alto Networks
PANW
$264B
| $19.5M | 0.04% |
278,800
+246,400
| +760% | +$19.8M |
|
453
Steris
STE
$20.9B
| $19.4M | 0.04% |
105,018
-275,364
| -72% | -$48.4M |
|
454
Trex
TREX
$4.51B
| $19.2M | 0.04% |
453,794
-96,165
| -17% | -$4.37M |
|
455
Royal Caribbean
RCL
$78.7B
| $19.2M | 0.04% |
387,571
+366,852
| +1,771% | +$19.2M |
|
456
PUT
Chevron
CVX
$388B
| $19.1M | 0.04% |
106,500
-100
| -0.1% | -$17.5K |
|
|
MBAC
457
DELISTED
M3-Brigade Acquisition II Corp.
MBAC
| $19M | 0.04% |
1,899,055
| – | – |
|
|
JNPR
458
DELISTED
Juniper Networks
JNPR
| $19M | 0.04% |
595,214
+365,510
| +159% | +$11.1M |
|
459
Albemarle
ALB
$13.5B
| $19M | 0.04% |
87,661
-101,002
| -54% | -$26.9M |
|
460
Clorox
CLX
$11.6B
| $19M | 0.04% |
135,046
+98,146
| +266% | +$13.9M |
|
|
ETNB
461
DELISTED
89bio
ETNB
| $18.9M | 0.04% |
1,487,311
+1,037,931
| +231% | +$9.34M |
|
|
ZING
462
DELISTED
FTAC Zeus Acquisition Corp. Class A Common Stock
ZING
| $18.9M | 0.04% |
1,870,985
-44,460
| -2% | -$446K |
|
463
Transocean
RIG
$5.92B
| $18.9M | 0.04% |
4,137,213
-139,772
| -3% | -$539K |
|
|
YTPG
464
DELISTED
TPG Pace Beneficial II Corp.
YTPG
| $18.9M | 0.04% |
1,921,003
| – | – |
|
465
Petrobras Class A
PBR.A
$107B
| $18.8M | 0.04% |
2,024,086
+1,267,824
| +168% | +$13.6M |
|
466
Philip Morris
PM
$301B
| $18.8M | 0.04% |
185,760
+62,870
| +51% | +$5.93M |
|
467
Truist Financial
TFC
$63.2B
| $18.8M | 0.04% |
435,907
+332,259
| +321% | +$14.6M |
|
|
NSTC
468
DELISTED
Northern Star Investment Corp. III
NSTC
| $18.6M | 0.04% |
1,852,694
| – | – |
|
469
PUT
State Street Financial Select Sector SPDR ETF
XLF
$55.6B
| $18.5M | 0.04% |
542,000
-70,400
| -11% | -$2.38M |
|
470
Twist Bioscience
TWST
$5.62B
| $18.5M | 0.04% |
778,202
-417,195
| -35% | -$12.1M |
|
|
NSTD
471
DELISTED
Northern Star Investment Corp. IV
NSTD
| $18.4M | 0.04% |
1,834,634
| – | – |
|
472
McCormick & Company Non-Voting
MKC
$13.4B
| $18.4M | 0.04% |
222,281
+211,881
| +2,037% | +$17.1M |
|
|
NSTB
473
DELISTED
Northern Star Investment Corp. II
NSTB
| $18.3M | 0.04% |
1,830,601
| – | – |
|
474
Fortune Brands Innovations
FBIN
$6.12B
| $18.3M | 0.04% |
320,503
-211,764
| -40% | -$11.1M |
|
|
TETC
475
DELISTED
Tech and Energy Transition Corporation Class A Common Stock
TETC
| $18.3M | 0.04% |
1,820,517
| – | – |
|
Similar funds
Marshall Wace's Q4 2022 Portfolio in Review
As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.
Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.
- Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
- Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
- Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
- Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
- Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
- Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
- Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.
Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.